The IPO will be undertaken in accordance with market conditions, regulatory approvals, and other necessary considerations. Previous Post US FDA approves Biocon Biologics' YESINTEK for autoimmune diseases Next Post Bonus, Stock Split Alert: An IT giant to issue free shares, PSU to pay dividend this week Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment